SHEP1 alleviates cardiac ischemia reperfusion injury via targeting G3BP1 to regulate macrophage infiltration and inflammation

Junbo Ge,Zhong Xin,Hua Li,Gao Tingwen,Guo Zhenyang,Xinyu Weng,Cui Yikai,Li Peng,Luo Wei,Hu Tao,Dong Zhen,Wei Peng,Cai Yun,Lu Yijing,Gao Rifeng

DOI: https://doi.org/10.21203/rs.3.rs-3964475/v1

2024-01-01

Abstract:Abstract Background: The macrophage-associated inflammation response plays an important role in myocardial ischemia-reperfusion injury (MIRI). During MIRI, the role and molecular mechanism of SHEP1 regulating macrophage remains unclear. Methods: By co-cultured with hypoxia reoxygenation cardiomyocytes in vitro, macrophages with SHEP1 knockout or overexpression were detected cell migration ability and related proinflammatory factors; and the molecular network regulated by SHEP1 was identified through transcriptome-wide analysis; then its target molecules were verified by co-immunoprecipitation method. In vivo, an ischemia-reperfusion heart model was established to observe the changes in cardiac function, cardiac tissue injury and inflammation of macrophage-specific deficiency of SHEP1 mice, and to analyze the improvement of cardiac function by administrating inhibitors for targeted molecules of SHEP1. Findings: The expression of SHEP1 was increased in macrophages co-cultured with hypoxia-reoxygenated cardiomyocytes and within ischemia-reperfusion injured myocardium at the early stage of injury. Cell migration and inflammation were also enhanced in SHEP1 knock-out macrophages and macrophage-specific deficiency of SHEP1 mice under MIRI, which further led to deteriorated cardiac injury and cardiac function in vivo. RNA-sequencing and co-immunoprecipitation mass spectrometry showed that macrophage-derived SHEP1 competitively bound to G3BP1 to suppress inflammation via the MAPK pathway. And administrating inhibitor of G3BP1 could improve cardiac function in macrophage-specific deficiency of SHEP1 mice under MIRI. Conclusions: SHEP1 targeted G3BP1 to antagonize cardiac ischemia-reperfusion injury by inhibiting infiltration and proinflammatory responses of macrophages, which provided a potential and clinically significant therapeutic target for MIRI.